中国性科学
中國性科學
중국성과학
THE CHINESE JOURNAL OF HUMAN SEXUALITY
2014年
8期
34-36
,共3页
盐酸坦洛新缓释片%给药方案%早泄
鹽痠坦洛新緩釋片%給藥方案%早洩
염산탄락신완석편%급약방안%조설
Tamsulosin hydrochloride sustained release tablets%Administration%Premature ejacu-lation
目的：探讨比较盐酸坦洛新缓释片的不同给药方案治疗早泄的临床效果。方法：选取2010年8月至2013年8月于我院进行治疗的243例早泄患者为研究对象，根据给药方案的不同将其随机分为0.2mg qd组、0.2mg bid组、0.4mg qd组，每组81例。将3组患者治疗前后对夫妻性生活的满意程度、阴道内射精潜伏期、CIPE评分进行统计比较。结果：3组患者治疗前的阴道内射精潜伏期分别为（0.71±0.23） min、（0.67±0.24）min、（0.69±0.19）min，P＞0.05，无统计学差异；治疗3个月后分别为（2.45±0.56）、（2.61±0.62）和（3.71±0.43）min，结果显示0.2mg qd组和0.2mg bid组差异无显著差异，0.4mg qd组与以上两组有显著的统计学差异（P＜0.05）。治疗后3组患者夫妻性生活满意度从高到低依次为：0.4mg qd组、0.2mg bid组、0.2mg qd组。治疗前3组患者CIPE 评分结果分别为（29.5±4.3）、（28.9±3.8）、（29.2±3.6）分，无统计学差异；治疗后分别为（32.2±3.1）、（35.9±3.1）、（37.5±3.7）分，其中0.4mg qd组与其他两组比CIPE评分结果明显增高，有统计学差异（P＜0.05）。结论：盐酸坦洛新缓释片的不同给药方案用于治疗早泄有不同的临床效果，1次/d给予0.4mg有更显著的临床治疗效果。
目的：探討比較鹽痠坦洛新緩釋片的不同給藥方案治療早洩的臨床效果。方法：選取2010年8月至2013年8月于我院進行治療的243例早洩患者為研究對象，根據給藥方案的不同將其隨機分為0.2mg qd組、0.2mg bid組、0.4mg qd組，每組81例。將3組患者治療前後對伕妻性生活的滿意程度、陰道內射精潛伏期、CIPE評分進行統計比較。結果：3組患者治療前的陰道內射精潛伏期分彆為（0.71±0.23） min、（0.67±0.24）min、（0.69±0.19）min，P＞0.05，無統計學差異；治療3箇月後分彆為（2.45±0.56）、（2.61±0.62）和（3.71±0.43）min，結果顯示0.2mg qd組和0.2mg bid組差異無顯著差異，0.4mg qd組與以上兩組有顯著的統計學差異（P＜0.05）。治療後3組患者伕妻性生活滿意度從高到低依次為：0.4mg qd組、0.2mg bid組、0.2mg qd組。治療前3組患者CIPE 評分結果分彆為（29.5±4.3）、（28.9±3.8）、（29.2±3.6）分，無統計學差異；治療後分彆為（32.2±3.1）、（35.9±3.1）、（37.5±3.7）分，其中0.4mg qd組與其他兩組比CIPE評分結果明顯增高，有統計學差異（P＜0.05）。結論：鹽痠坦洛新緩釋片的不同給藥方案用于治療早洩有不同的臨床效果，1次/d給予0.4mg有更顯著的臨床治療效果。
목적：탐토비교염산탄락신완석편적불동급약방안치료조설적림상효과。방법：선취2010년8월지2013년8월우아원진행치료적243례조설환자위연구대상，근거급약방안적불동장기수궤분위0.2mg qd조、0.2mg bid조、0.4mg qd조，매조81례。장3조환자치료전후대부처성생활적만의정도、음도내사정잠복기、CIPE평분진행통계비교。결과：3조환자치료전적음도내사정잠복기분별위（0.71±0.23） min、（0.67±0.24）min、（0.69±0.19）min，P＞0.05，무통계학차이；치료3개월후분별위（2.45±0.56）、（2.61±0.62）화（3.71±0.43）min，결과현시0.2mg qd조화0.2mg bid조차이무현저차이，0.4mg qd조여이상량조유현저적통계학차이（P＜0.05）。치료후3조환자부처성생활만의도종고도저의차위：0.4mg qd조、0.2mg bid조、0.2mg qd조。치료전3조환자CIPE 평분결과분별위（29.5±4.3）、（28.9±3.8）、（29.2±3.6）분，무통계학차이；치료후분별위（32.2±3.1）、（35.9±3.1）、（37.5±3.7）분，기중0.4mg qd조여기타량조비CIPE평분결과명현증고，유통계학차이（P＜0.05）。결론：염산탄락신완석편적불동급약방안용우치료조설유불동적림상효과，1차/d급여0.4mg유경현저적림상치료효과。
To observe and compare the clinical effect of different administrations of tamsulosin hydrochloride sustained release tablets in treating premature ejaculation.Methods:243 patients with premature e-jaculation treated in our hospital from August 2010 to August 2013 were selected as research objects and divided into three groups randomly,0.2mg qd group,0.2mgbid group and 0.4mg qd group,each group for 81 patients.The satisfactory degree of married couple sex life,intravaginal ejaculatory latency time and CIPE score before and after treatment of three groups were compared.Results:The intravaginal ejaculatory latency time of three groups before treatment were (0.71 ±0.23)min,(0.67 ±0.24)min and (0.69 ±0.19)min,P>0.05,which had no statistical significance,and that 3 months after treatment were (2.45 ±0.56),(2.61 ±0.62)and (3.71 ±0.43)min.The result indicated that there was no evident difference between 0.2mg qd group and 0.2mg bid group,and there was evident statistical significance between 0.4mg qd group and the other two groups(P<0.05 ).The satisfactory de-gree of married couple sex life of three groups after treatment in order was 0.4mg qd group,0.2mg bid group and 0.2mg qd group.CIPE score of three groups before treatment was (29.5 ±4.3),(28.9 ±3.8)and (29.2 ±3.6) respectively,which had no statistical significance,and that after treatment was (32.2 ±3.1 ),(35.9 ±3.1 )and (37.5 ±3.7),in which 0.4mg qd group increased evidently compared with that of the other two groups,which had statistical significance(P<0.05 ).Conclusion:Different administrations of tamsulosin hydrochloride sustained re-lease tablets have different clinical effect in treating premature ejaculation,and giving 0.4mg once everyday has more evident clinical treatment effect.
